Related Experiment Video
Updated: Feb 11, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Statins use and cancer: an update.
Martyna Zaleska1, Olga Mozenska1, Jacek Bil2
1Department of Cardiology & Hypertension, Central Clinical Hospital of the Ministry of Interior & Administration, Warsaw, Poland.
Statins show antitumor, cytostatic, and cytotoxic effects, challenging early cancer concerns. Recent clinical data and meta-analyses confirm their safety and potential benefits in cancer patients.
Area of Science:
- Oncology
- Pharmacology
- Clinical Medicine
Background:
- Initial concerns linked statins to increased cancer incidence and mortality.
- Emerging evidence suggests statins possess antitumor properties.
- Understanding statin's role in cancer treatment is crucial.
Purpose of the Study:
- To review preclinical mechanisms of statin's antineoplastic activity.
- To examine the influence of statins on cancer treatment outcomes.
- To analyze recent clinical data on statins, cancer incidence, and mortality.
Main Methods:
- Review of preclinical research on statin mechanisms.
- Analysis of observational clinical trials.
- Synthesis of meta-analyses data.
Main Results:
- Preclinical studies reveal statins' cytostatic and cytotoxic effects.
- Recent clinical data and meta-analyses indicate no increased cancer risk with statin use.
- Potential for statins to positively influence cancer treatment outcomes.
Conclusions:
- Statins exhibit significant antineoplastic potential.
- Current evidence refutes earlier concerns about statins and cancer.
- Statins may offer benefits for cancer patients.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

